Sirt1, A negative regulator of matrix metalloproteinase-9 in diabetic retinopathy

Investigative Ophthalmology and Visual Science

Volumn 55, Issue 9, 2014, Pages 5653-5660

  Kowluru, Renu A ^a   Santos, Julia M ^a   Zhong, Qing ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

Diabetic Retinopathy; MMP 9; NF kB; Posttranslational Modification; Sirt1

Indexed keywords

4', 6 DIAMIDINO 2 PHENYLINDOLE; BETA ACTIN; COMPLEMENTARY DNA; GELATINASE B; GLUCOSE; HYDROGEN PEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MONOCLONAL ANTIBODY; REACTIVE OXYGEN METABOLITE; RESVERATROL; SIRTUIN 1; STREPTOZOCIN; SYNAPTOTAGMIN I; UNCLASSIFIED DRUG; CYTOCHROME B; ENZYME INHIBITOR; HISTONE DEACETYLASE; STILBENE DERIVATIVE;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DEACETYLATION; DIABETIC RETINOPATHY; DNA PROTEIN COMPLEX; ENDOTHELIUM CELL; GELATINASE B GENE; GENE; GENE OVEREXPRESSION; GENETIC REGULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MANGANESE SUPEROXIDE DISMUTASE GENE; MITOCHONDRION; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROMOTER REGION; PROTEIN ACETYLATION; PROTEIN PROCESSING; PROTEIN SYNTHESIS INHIBITION; REAL TIME POLYMERASE CHAIN REACTION; RETINA CAPILLARY; WESTERN BLOTTING; ANALYSIS OF VARIANCE; ANIMAL; C57BL MOUSE; CASE CONTROL STUDY; CHEMISTRY; FEMALE; KNOCKOUT MOUSE; MALE; METABOLISM; MIDDLE AGED; MMP-9; NF-KB; PHYSIOLOGY; RETINA; SIRT1;

DIABETIC RETINOPATHY; MMP-9; NF-KB; POSTTRANSLATIONAL MODIFICATION; SIRT1;

AGED; ANALYSIS OF VARIANCE; ANIMALS; APOPTOSIS; CASE-CONTROL STUDIES; CYTOCHROMES B; DIABETIC RETINOPATHY; ENDOTHELIAL CELLS; ENZYME INHIBITORS; FEMALE; HISTONE DEACETYLASES; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MIDDLE AGED; MITOCHONDRIA; OXIDATIVE STRESS; RETINA; SIRTUIN 1; STILBENES;

EID: 84908110233     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.14-14383     Document Type: Article

References (55)

1. Engerman RL, Kern TS. Hyperglycemia as a cause of diabetic retinopathy. Metabolism. 1986;35:20-23.
2. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-986.
3. Frank RN. Diabetic retinopathy. N Engl J Med. 2004;350:48-58.
4. Kowluru RA, Zhong Q, Santos JM. Matrix metalloproteinases in diabetic retinopathy: Potential role of MMP-9. Expert Opin Investig Drugs. 2012;21:797-805.
5. Petrovic D. Candidate genes for proliferative diabetic retinopathy. Biomed Res Int. 2013;2013:540416.
6. Giebel SJ, Menicucci G, McGuire PG, Das A. Matrix metalloproteinases in early diabetic retinopathy and their role in alteration of the blood-retinal barrier. Lab Invest. 2005;85: 567-607.
7. Grant MB, Caballero S, Tarnuzzer RW, et al. Matrix metalloproteinase expression in human retinal microvascular cells. Diabetes. 1998;47:1311-1317.
8. Kowluru RA. Role of matrix metalloproteinase-9 in the development of diabetic retinopathy and its regulation by HRas. Invest Ophthalmol Vis Sci. 2010;51:4320-4326.
9. Kowluru RA, Mohammad G, Dos Santos JM, Zhong Q. Abrogation of MMP9 gene protects against the development of retinopathy in diabetic mice by preventing mitochondrial damage. Diabetes. 2011;60:3023-3033.
10. Mohammad G, Kowluru RA. Diabetic retinopathy and signaling mechanism for activation of matrix metalloproteinase-9. J Cell Physiol. 2012;227:1052-1061.
11. Zhong Q, Kowluru RA. Regulation of matrix metalloproteinase- 9 by epigenetic modifications and the development of diabetic retinopathy. Diabetes. 2013;62:2559-2568.
12. Tang CH, Tsai CC. Ccl2 increases MMP-9 expression and cell motility in human chondrosarcoma cells via the Ras/Raf/MEK/ ERK/NF-jB signaling pathway. Biochem Pharmacol. 2012;83: 335-344.
13. Robert I, Aussems M, Keutgens A, et al. Metalloproteinase-9 gene induction by a truncated oncogenic NF-Kappab2 protein involves the recruitment of Mll1 and Mll2 H3K4 histone methyltransferase complexes. Oncogene. 2009;28:1626-1628.
14. Liu P, Wilson MJ. miR-520c and miR-373 upregulate MMP9 expression by targeting mTOR and SIRT1, and activate the Ras/Raf/MEK/Erk signaling pathway and NF-kappaB factor in human fibrosarcoma cells. J Cell Physiol. 2012;227:867-876.
15. Jung YJ, Lee JE, Lee AS, et al. Sirt1 overexpression decreases cisplatin-induced acetylation of NF-Kappab p65 subunit and cytotoxicity in renal proximal tubule cells. Biochem Biophys Res Commun. 2012;419:206-210.
16. Pavlova S, Klucska K, Vasicek D, et al. The involvement of Sirt1 and transcription factor NF-Kappab (p50/p65) in regulation of porcine ovarian cell function. Anim Reprod Sci. 2013;140: 180-188.
17. Lee SJ, Kim MM. Resveratrol with antioxidant activity inhibits matrix metalloproteinase via modulation of Sirt1 in human fibrosarcoma cells. Life Sci. 2011;88:465-472.
18. Sundar IK, Caito S, Yao H, Rahman I. Oxidative stress, thiol redox signaling methods in epigenetics. Methods Enzymol. 2010;474:213-244.
19. Zee RS, Yoo CB, Pimentel DR, et al. Redox regulation of sirtuin-1 by s-glutathiolation. Antioxid Redox Signal. 2010;13: 1023-1032.
20. Hwang JW, Yao H, Caito S, Sundar IK, Rahman I. Redox regulation of Sirt1 in inflammation and cellular senescence. Free Radic Biol Med. 2013;61C:95-110.
21. Chen F, Qian LH, Deng B, Liu ZM, Zhao Y, Le YY. Resveratrol protects vascular endothelial cells from high glucose-induced apoptosis through inhibition of NADPH oxidase activationdriven oxidative stress. CNS Neurosci Ther. 2013;19:675-681.
22. Kowluru V, Kowluru RA. Increased oxidative stress in diabetes regulates activation of a small molecular weight g-protein, HRas, in the retina. Mol Vis. 2007;13:602-610.
23. Santos JM, Tewari S, Goldberg AFX, Kowluru RA. Mitochondria biogenesis and the development of diabetic retinopathy. Free Rad Biol Med. 2011;51:1849-1860.
24. Kowluru RA, Kowluru V, Ho YS, Xiong Y. Overexpression of mitochondrial superoxide dismutase in mice protects the retina from diabetes-induced oxidative stress. Free Rad Biol Med. 2006;41:1191-1196.
25. Madsen-Bouterse SA, Mohammad G, Kanwar M, Kowluru RA. Role of mitochondrial DNA damage in the development of diabetic retinopathy, and the metabolic memory phenomenonassociated with its progression. Antioxid Redox Signal. 2010; 13:797-805.
26. Kowluru RA, Kowluru A, Veluthakal R, et al. Tiam1-Rac1 signaling axis mediated activation of NADPH oxidase-2 initiates mitochondrial damage in the development of diabetic retinopathy. Diabetologia. 2014;57:1047-1056.
27. Zhong Q, Kowluru RA. Epigenetic changes in mitochondrial superoxide dismutase in the retina and the development of diabetic retinopathy. Diabetes. 2011;60:1304-1313.
28. Zhong Q, Kowluru RA. Epigenetic modification of Sod2 in the development of diabetic retinopathy and in the metabolic memory: role of histone methylation. Invest Ophthalmol Vis Sci. 2013;54:244-250.
29. Zhong Q, Mishra M, Kowluru RA. Transcription factor Nrf2- mediated antioxidant defense system in the development of diabetic retinopathy. Invest Ophthalmol Vis Sci. 2013;54: 3941-3948.
30. Santos JM, Tewari S, Lin JY, Kowluru RA. Interrelationship between activation of matrix metalloproteinases and mitochondrial dysfunction in the development of diabetic retinopathy. Biochem Biophys Res Commun. 2013;438:760-764.
31. Santos JM, Mishra M, Kowluru RA. Posttranslational modification of mitochondrial transcription factor A in impaired mitochondria biogenesis: implications in diabetic retinopathy and metabolic memory phenomenon. Exp Eye Res. 2014;121: 168-177.
32. Kowluru RA, Tang J, Kern TS. Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy. Diabetes. 2001;50:1938-1942.
33. Caito S, Rajendrasozhan S, Cook S, et al. Sirt1 is a redoxsensitive deacetylase that is post-translationally modified by oxidants and carbonyl stress. FASEB J. 2010;24:3145-3159.
34. Sato H, Seiki M. Regulatory mechanism of 92 Kda type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene. 1993;8:395-405.
35. Xu B, Chen H, Xu W, et al. Molecular mechanisms of MMP9 overexpression and its role in emphysema pathogenesis of SMAD3-deficient mice. Am J Physiol Lung Cell Mol Physiol. 2012;303:L89-L96.
36. Brooks CL, Gu W. How does sirt1 affect metabolism, senescence and cancer? Nat Rev Cancer. 2009;9:123-128.
37. Chung S, Yao H, Caito S, Hwang JW, Arunachalam G, Rahman I. Regulation of Sirt1 in cellular functions: role of polyphenols. Arch Biochem Biophys. 2010;501:79-90.
38. Yu J, Auwerx J. Protein deacetylation by sirt1: An emerging key post-translational modification in metabolic regulation. Pharmacol Res. 2010;62:35-41.
39. Kauppinen A, Suuronen T, Ojala J, Kaarniranta K, Salminen A. Antagonistic crosstalk between NF-Kappab and Sirt1 in the regulation of inflammation and metabolic disorders. Cell Signal. 2013;25:1939-1948.
40. Menzies KJ, Hood DA. The role of Sirt1 in muscle mitochondrial turnover. Mitochondrion. 2012;12:5-13.
41. Jaliffa C, Ameqrane I, Dansault A, et al. Sirt1 involvement in rd10 mouse retinal degeneration. Invest Ophthalmol Vis Sci. 2009;50:3562-3572.
42. Mimura T, Kaji Y, Noma H, Funatsu H, Okamoto S. The role of Sirt1 in ocular aging. Exp Eye Res. 2013;116:17-26.
43. Kowluru RA, Abbas SN. Diabetes-induced mitochondrial dysfunction in the retina. Invest Ophthalmol Vis Sci. 2003; 44:5327-5334.
44. Mizutani M, Kern TS, Lorenzi M. Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy. J Clin Invest. 1996;97:2883-2890.
45. Kern TS, Tang J, Mizutani M, Kowluru R, Nagraj R, Lorenzi M. Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia. Invest Ophthalmol Vis Sci. 2000;41:3972-3978.
46. Romeo G, Liu WH, Asnaghi V, Kern TS, Lorenzi M. Activation of nuclear factor-kappab induced by diabetes and high glucose regulates a proapoptotic program in retinal pericytes. Diabetes. 2002;51:2241-2248.
47. Kowluru RA, Koppolu P, Chakrabarti S, Chen S. Diabetesinduced activation of nuclear transcriptional factor in the retina, and its inhibition by antioxidants. Free Radic Research. 2003;37:1169-1180.
48. Yeung F, Hoberg JE, Ramsey CS, et al. Modulation of NFKappab- dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J. 2004;23:2369-2380.
49. Yang XD, Tajkhorshid E, Chen LF. Functional interplay between acetylation and methylation of the RelA subunit of NF-kappaB. Mol Cell Biol. 2010;30:2170-2180.
50. Zheng Z, Chen H, Li J, et al. Sirtuin 1-mediated cellular metabolic memory of high glucose via the Ikb1/AMPK/ROS pathway and therapeutic effects of metformin. Diabetes. 2012;61:217-228.
51. Chen H, Wan Y, Zhou S, et al. Endothelium-specific sirt1 overexpression inhibits hyperglycemia-induced upregulation of vascular cell senescence. Sci China Life Sci. 2012;55:467-473.
52. Kern TS, Kowluru R, Engerman RL. Abnormalities of retinal metabolism in diabetes or galactosemia. ATPases and glutathione. Invest Ophthalmol Vis Sci. 1994;35:2962-2967.
53. Kanwar M, Kowluru RA. Role of glyceraldehyde 3-phosphate dehydrogenase in the development and progression of diabetic retinopathy. Diabetes. 2009;58:227-234.
54. Kanwar M, Chan PS, Kern TS, Kowluru RA. Oxidative damage in the retinal mitochondria of diabetic mice: possible protection by superoxide dismutase. Invest Ophthalmol Vis Sci. 2007;48:3805-3811.
55. Tewari S, Santos JM, Kowluru RA. Damaged mitochondrial DNA replication system and the development of diabetic retinopathy. Antioxid Redox Signal. 2012;17:492-504.